UK markets close in 2 hours 51 minutes
  • FTSE 100

    6,878.89
    -10.23 (-0.15%)
     
  • FTSE 250

    22,193.96
    +40.41 (+0.18%)
     
  • AIM

    1,238.50
    +3.81 (+0.31%)
     
  • GBP/EUR

    1.1533
    +0.0002 (+0.01%)
     
  • GBP/USD

    1.3742
    +0.0000 (+0.00%)
     
  • BTC-GBP

    45,850.01
    +1,837.64 (+4.18%)
     
  • CMC Crypto 200

    1,337.92
    +43.34 (+3.35%)
     
  • S&P 500

    4,127.99
    -0.81 (-0.02%)
     
  • DOW

    33,745.40
    -55.20 (-0.16%)
     
  • CRUDE OIL

    60.17
    +0.47 (+0.79%)
     
  • GOLD FUTURES

    1,733.20
    +0.50 (+0.03%)
     
  • NIKKEI 225

    29,751.61
    +212.88 (+0.72%)
     
  • HANG SENG

    28,497.25
    +43.97 (+0.15%)
     
  • DAX

    15,244.26
    +29.26 (+0.19%)
     
  • CAC 40

    6,176.88
    +15.20 (+0.25%)
     

Melanoma - Competitive Landscape to 2026

ReportLinker
·2-min read

Summary "Melanoma - Competitive Landscape to 2026" combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

New York, March 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Melanoma - Competitive Landscape to 2026" - https://www.reportlinker.com/p06035009/?utm_source=GNW


PD-1 targeting immunotherapies are the major focus of drug developers.There are 689 drugs in the pipeline, 47 of which targets PD-1.

Big pharma dominates R&D in this indication, with BMS, Roche, Novartis, GSK, Merck & Co. and Pfizer leading the way. Increasing incidence expected to drive the growth in Melanoma market.

This reports provides a data-driven overview of the current and future competitive landscape in melanoma therapeutics.

Scope
Components of the report include -
- Disease epidemiology
- Marketed drugs assessment
- Pipeline drugs assessment
- Clinical trials assessment
- Commercial assessment
- Social media overview
- Digital marketing overview

Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global melanoma market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global melanoma market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Read the full report: https://www.reportlinker.com/p06035009/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001